WallStSmart

Cresud SACIF y A (CRESY)vsPACCAR Inc (PCAR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cresud SACIF y A generates 4859% more annual revenue ($1.38T vs $27.82B). CRESY leads profitability with a 12.9% profit margin vs 9.0%. CRESY trades at a lower P/E of 6.4x. PCAR earns a higher WallStSmart Score of 54/100 (C-).

CRESY

Buy

50

out of 100

Grade: C-

Growth: 6.0Profit: 6.0Value: 6.7Quality: 4.5
Piotroski: 6/9Altman Z: 0.90

PCAR

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 6.0Value: 5.3Quality: 7.0
Piotroski: 2/9Altman Z: 2.57
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRESY.

PCARSignificantly Overvalued (-36.8%)

Margin of Safety

-36.8%

Fair Value

$85.78

Current Price

$114.73

$28.95 premium

UndervaluedFair: $85.78Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRESY3 strengths · Avg: 9.3/10
P/E RatioValuation
6.4x10/10

Attractively priced relative to earnings

Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Free Cash FlowQuality
$4.88B8/10

Generating 4.9B in free cash flow

PCAR3 strengths · Avg: 8.3/10
Market CapQuality
$64.60B9/10

Large-cap with strong market position

PEG RatioValuation
1.008/10

Growing faster than its price suggests

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

Areas to Watch

CRESY4 concerns · Avg: 2.5/10
Market CapQuality
$861.03M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.503/10

Elevated debt levels

EPS GrowthGrowth
-50.3%2/10

Earnings declined 50.3%

Altman Z-ScoreHealth
0.902/10

Distress zone — elevated risk

PCAR4 concerns · Avg: 3.8/10
P/E RatioValuation
25.8x4/10

Moderate valuation

Revenue GrowthGrowth
0.5%4/10

0.5% revenue growth

EPS GrowthGrowth
4.2%4/10

4.2% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CRESY

The strongest argument for CRESY centers on P/E Ratio, Price/Book, Free Cash Flow.

Bull Case : PCAR

The strongest argument for PCAR centers on Market Cap, PEG Ratio, Price/Book. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bear Case : CRESY

The primary concerns for CRESY are Market Cap, Debt/Equity, EPS Growth. Debt-to-equity of 1.50 is elevated, increasing financial risk.

Bear Case : PCAR

The primary concerns for PCAR are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

PCAR carries more volatility with a beta of 0.97 — expect wider price swings.

CRESY is growing revenue faster at 8.3% — sustainability is the question.

CRESY generates stronger free cash flow (4.9B), providing more financial flexibility.

Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PCAR scores higher overall (54/100 vs 50/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cresud SACIF y A

INDUSTRIALS · CONGLOMERATES · USA

Cresud Sociedad Annima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces agricultural commodities in Brazil and other Latin American countries. The company is headquartered in Buenos Aires, Argentina.

Visit Website →

PACCAR Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.

Want to dig deeper into these stocks?